cetylpyridinium chloride anhydrous has been researched along with losartan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, M; Kazdová, L; Klementová, M; Kopecký, J; Krusinová, E; Mlejnek, P; Pelikánová, T; Pravenec, M; Wohl, P | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and losartan
Article | Year |
---|---|
Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects.
Topics: Adiponectin; Adult; Angiotensin II Type 1 Receptor Blockers; Drug Combinations; Gene Expression; Glucose Clamp Technique; Health; Humans; Hyperinsulinism; Insulin; Intra-Abdominal Fat; Losartan; Male; Receptor, Angiotensin, Type 1; Resistin | 2007 |